EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The development and validation in hypertensive patients of the Health Belief Model for pharmacological adherence (HBM-FA) scale

Lázaro Pablo Linares Cánovas, Guillermo Luís Herrera Miranda, Liyansis Bárbara Linares Cánovas, Barbarito Malagón Silva, Wiliam Ismel Sánchez Muñoz, Geovani López Ortiz

South Health and Policy · 29.04.2025 · 4 · 229

DOI: 10.56294/shp2025229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift South Health and Policy, online erschienen am 29.04.2025. Verfasst von Lázaro Pablo Linares Cánovas und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: pharmacological adherence in hypertensive patients is essential, so the study of the factors that influence it is essential.Objective: to develop and validate a scale based on the health belief model to measure factors influencing drug adherence in hypertensive patients.Methods: the development process of the HBM-FAS scale included the review of the literature, the generation of the items that conformed it (grouped in the six constructs that respond to the theoretical framework of the Health Belief Model), the evaluation of its content by a panel of experts, and the subsequent application of a pilot test. A confirmatory factor analysis of the proposed model was carried out, and its validity and reliability were subsequently evaluated. Results: a panel of experts evaluated the content validity of the instrument, showing a high degree of content validity. The CFA indicated poor fit indices (CFI=.763; TLI=.735; RMSEA=.118; SRMR=.143; CMIN/DF=.07), leading to modifications (removal of 9 out of 30 items). The refined model showed an acceptable fit (CMIN/DF=1.69; CFI=.977; TLI=.972; SRMR=.0393; RMSEA=.0434). The scale demonstrated high internal consistency reliability (.895) as well as good discriminant validity.Conclusions: the HBM-FA scale showed good psychometric properties, being suitable for measuring health beliefs associated with pharmacological adherence in hypertensive patients, which makes its use in future intervention studies beneficial.

Zitieren

APA

Cánovas, L. P. L., Miranda, G. L. H., Cánovas, L. B. L., Silva, B. M., Muñoz, W. I. S., & Ortiz, G. L. (2025). The development and validation in hypertensive patients of the Health Belief Model for pharmacological adherence (HBM-FA) scale. South Health and Policy, 4, 229. https://doi.org/10.56294/shp2025229

Vancouver

Cánovas LPL, Miranda GLH, Cánovas LBL, Silva BM, Muñoz WIS, Ortiz GL. The development and validation in hypertensive patients of the Health Belief Model for pharmacological adherence (HBM-FA) scale. South Health and Policy. 2025;4:229. doi:10.56294/shp2025229

BibTeX
@article{Cnovas2025,
  author = {Cánovas, Lázaro Pablo Linares and Miranda, Guillermo Luís Herrera and Cánovas, Liyansis Bárbara Linares and Silva, Barbarito Malagón and Muñoz, Wiliam Ismel Sánchez and Ortiz, Geovani López},
  title = {The development and validation in hypertensive patients of the Health Belief Model for pharmacological adherence (HBM-FA) scale},
  journal = {South Health and Policy},
  year = {2025},
  volume = {4},
  pages = {229},
  doi = {10.56294/shp2025229}
}
Kostenlos starten →